DA-1301

N/A

Report date: 2026/04/07 20:00:20

Base Information

Drug NameDA-1301
Drug Alias NameDA-1301
ClassificationCell and gene therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsInflammationNeurodegenerative Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDong-A ST Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDong-A ST Co Ltd
Inactive CompaniesN/A
Active IndicationsInflammationNeurodegenerative Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A